Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials

TW Clark, JS Tregoning, H Lister, T Poletti… - Clinical Microbiology …, 2024 - journals.asm.org
SUMMARY In the United Kingdom (UK) in 2022/23, influenza virus infections returned to the
levels recorded before the COVID-19 pandemic, exerting a substantial burden on an already …

[HTML][HTML] Summary of the National Advisory Committee on Immunization (NACI) Supplemental Guidance on Influenza Vaccination in Adults 65 Years of Age and Older

P Doyon-Plourde, A Sinilaite… - Canada Communicable …, 2024 - pmc.ncbi.nlm.nih.gov
Background Adults 65 years of age and older are at higher risk of influenza complications,
such as hospitalization and death. As a result, seasonal influenza immunization is …

[PDF][PDF] Résumé des directives supplémentaires du Comité consultatif national de l'immunisation (CCNI) sur la vaccination antigrippale chez les adultes de 65 ans et …

P Doyon-Plourde, A Sinilaite, J Papenburg - Canada Communicable …, 2024 - canada.ca
Résumé Contexte: Les adultes de 65 ans et plus présentent un risque plus élevé de
complications liées à la grippe, telles que l'hospitalisation et le décès. La vaccination contre …

Formulation and Evaluation of Bivalent Swine and Avian Lipid Nanoparticles mRNA Vaccine

MMS Kassab - 2024 - preprints.org
Background: Worldwide, Swine and Avian influenza, or the H1N1 and H5N1 serotypes of
the Influenza A virus, is a highly contagious illness. In recent years, the global incidence of …